Insider · CIK 0001380184
Zsolt Harsanyi
chairofficerdirector
Files at EBS (Emergent BioSolutions Inc.), APVO (Aptevo Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Jul 21, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +34,403 | $0.00 | $0 | 123,732 | May 2, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,824 | $0.00 | $0 | 41,572 | May 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.